The Institutional Conflict of Interest Committee has approved a revised version of the Office of the President’s Policy for Institutional Conflicts of Interest in Research that will take effect Feb. 1.
The updated policy clarifies the criteria for the financial interest disclosure of and the management of conflicts of interest associated with:
• Technology transfer licensing agreements where the university, as an institution, has a contractual right to acquire equity or receive certain fees from a third party under the terms of the agreement to license or option UM-developed intellectual property.
• University investments through, or agreements on behalf of, Michigan Invests in New Technology Startups, Michigan Biomedical Venture Fund, Accelerate Blue and any similar university-controlled investment funds.
The Office of the President’s ICOI policy and disclosure procedures demonstrate to the U-M research community, our research sponsors, and external research collaborators the University’s commitment to the reduction or elimination of bias, or the appearance of bias, in U-M research activities.